Gland Pharma Limited Accounts Payable for the year ending March 31, 2025: USD 96.00 M

Gland Pharma Limited Accounts Payable is USD 96.00 M for the year ending March 31, 2025, a -7.18% change year over year. Accounts payable are amounts owed by the company to suppliers or vendors for goods or services received but not yet paid.
  • Gland Pharma Limited Accounts Payable for the year ending March 31, 2024 was USD 103.43 M, a 44.73% change year over year.
  • Gland Pharma Limited Accounts Payable for the year ending March 31, 2023 was USD 71.46 M, a 17.23% change year over year.
  • Gland Pharma Limited Accounts Payable for the year ending March 31, 2022 was USD 60.96 M, a 12.61% change year over year.
  • Gland Pharma Limited Accounts Payable for the year ending March 31, 2021 was USD 54.13 M, a 63.76% change year over year.
Key Data
Date Accounts Payable Short-Term Debt Long-Term Debt Total Liabilities